{"id":"https://openalex.org/W2078747149","doi":"https://doi.org/10.1097/ftd.0b013e3182603f62","title":"Plasma Concentrations of Quetiapine, N-Desalkylquetiapine, O-Desalkylquetiapine, 7-Hydroxyquetiapine, and Quetiapine Sulfoxide in Relation to Quetiapine Dose, Formulation, and Other Factors","display_name":"Plasma Concentrations of Quetiapine, N-Desalkylquetiapine, O-Desalkylquetiapine, 7-Hydroxyquetiapine, and Quetiapine Sulfoxide in Relation to Quetiapine Dose, Formulation, and Other Factors","alternate_titles":[],"publication_year":2012,"publication_date":"2012-07-07","ids":{"openalex":"https://openalex.org/W2078747149","doi":"https://doi.org/10.1097/ftd.0b013e3182603f62","mag":"2078747149","pmid":"https://pubmed.ncbi.nlm.nih.gov/22777152"},"language":"en","primary_location":{"id":"doi:10.1097/ftd.0b013e3182603f62","doi":"https://doi.org/10.1097/ftd.0b013e3182603f62","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ftd.0b013e3182603f62","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2078747149"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067459400","display_name":"Danielle S. Fisher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111135","display_name":"King's College Hospital NHS Foundation Trust","ror":"https://ror.org/01n0k5m85","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Danielle S. Fisher","raw_affiliation_strings":["Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King's College Hospital NHS Foundation Trust, London, United Kingdom. danielle.fisher@nhs.net","Danielle Fisher, MSc, Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, United Kingdom (e-mail: [email\u00a0protected])","Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King's College Hospital NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King's College Hospital NHS Foundation Trust, London, United Kingdom. danielle.fisher@nhs.net","institution_ids":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]},{"raw_affiliation_string":"Danielle Fisher, MSc, Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, United Kingdom (e-mail: [email\u00a0protected])","institution_ids":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]},{"raw_affiliation_string":"Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King's College Hospital NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024664789","display_name":"Simon Alfred Handley","orcid":"https://orcid.org/0000-0002-9237-8136","observed_orcids":["https://orcid.org/0000-0002-9237-8136"]},"institutions":[{"id":"https://openalex.org/I4210111135","display_name":"King's College Hospital NHS Foundation Trust","ror":"https://ror.org/01n0k5m85","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Simon A. Handley","raw_affiliation_strings":["Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King's College Hospital NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King's College Hospital NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061732313","display_name":"Robert James Flanagan","orcid":"https://orcid.org/0000-0003-1081-7463","observed_orcids":["https://orcid.org/0000-0003-1081-7463"]},"institutions":[{"id":"https://openalex.org/I4210111135","display_name":"King's College Hospital NHS Foundation Trust","ror":"https://ror.org/01n0k5m85","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Robert J. Flanagan","raw_affiliation_strings":["Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King's College Hospital NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King's College Hospital NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014436895","display_name":"David M. Taylor","orcid":"https://orcid.org/0000-0002-2557-1710","observed_orcids":["https://orcid.org/0000-0002-2557-1710"]},"institutions":[{"id":"https://openalex.org/I4210115181","display_name":"Maudsley Hospital","ror":"https://ror.org/02788t795","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200323923","https://openalex.org/I4210115181"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David M. Taylor","raw_affiliation_strings":["Pharmacy Department, Maudsley Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department, Maudsley Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I4210115181"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5024664789","https://openalex.org/A5061732313","https://openalex.org/A5067459400"],"corresponding_institution_ids":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"],"apc_list":null,"apc_paid":null,"fwci":1.9829,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.81879195,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"34","issue":"4","first_page":"415","last_page":"421"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8906000256538391,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8906000256538391,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.06379999965429306,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.024299999698996544,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.6019999980926514},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.6359999775886536},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.7200000286102295},{"id":"https://openalex.org/keywords/immediate-release-formulation","display_name":"immediate-release formulation","score":0.8690000176429749},{"id":"https://openalex.org/keywords/antipsychotic-exposure","display_name":"antipsychotic exposure","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.9870054721832275},{"id":"https://openalex.org/C2911140283","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine Fumarate","level":5,"score":0.7694734334945679},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4387645423412323},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40437284111976624},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.33856815099716187},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2599927484989166},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.22817277908325195},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.13496151566505432},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.0976845920085907}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012451","descriptor_name":"Safrole","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D012451","descriptor_name":"Safrole","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/ftd.0b013e3182603f62","doi":"https://doi.org/10.1097/ftd.0b013e3182603f62","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ftd.0b013e3182603f62","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmid:22777152","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22777152","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Journal Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/25f2086f-a4b3-4000-bafc-f0a742c7d9e3","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/25f2086f-a4b3-4000-bafc-f0a742c7d9e3","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fisher, D, Handley, S, Flanagan, B & Taylor, D 2012, 'Plasma concentrations of quetiapine, n-desalkyquetiapine, o-desalkylquetiapine, 7-hydroxyquetiapine and quetiapine sulfoxide in relation to quetiapine dose, formulation and other factors', Therapeutic Drug Monitoring, vol. 34, no. 4, pp. 415-421. https://doi.org/10.1097/FTD.0b013e3182603f62","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W59829318","https://openalex.org/W189193018","https://openalex.org/W1736583785","https://openalex.org/W1738433183","https://openalex.org/W1869439357","https://openalex.org/W1890249102","https://openalex.org/W1964648414","https://openalex.org/W1987892448","https://openalex.org/W1990663756","https://openalex.org/W2001210379","https://openalex.org/W2005120328","https://openalex.org/W2009666409","https://openalex.org/W2010143198","https://openalex.org/W2012655610","https://openalex.org/W2021696580","https://openalex.org/W2021872048","https://openalex.org/W2026351331","https://openalex.org/W2028449820","https://openalex.org/W2033342358","https://openalex.org/W2037583123","https://openalex.org/W2038235070","https://openalex.org/W2041948429","https://openalex.org/W2042517153","https://openalex.org/W2045152337","https://openalex.org/W2058415448","https://openalex.org/W2071403548","https://openalex.org/W2074852398","https://openalex.org/W2075094571","https://openalex.org/W2078154303","https://openalex.org/W2080724513","https://openalex.org/W2080826919","https://openalex.org/W2091962144","https://openalex.org/W2096739998","https://openalex.org/W2122710476","https://openalex.org/W2125138227","https://openalex.org/W2139280604","https://openalex.org/W2139990448","https://openalex.org/W2148920664","https://openalex.org/W2155079167","https://openalex.org/W2161206050","https://openalex.org/W2164398896","https://openalex.org/W2323680035","https://openalex.org/W2324041604"],"related_works":["https://openalex.org/W7213985580","https://openalex.org/W189193018","https://openalex.org/W2611093812","https://openalex.org/W2131371851","https://openalex.org/W2388524749","https://openalex.org/W2011718486","https://openalex.org/W2058415448","https://openalex.org/W2075094571","https://openalex.org/W2087728278","https://openalex.org/W2075699872"],"abstract_inverted_index":{"BACKGROUND:":[0],"N-Desalkylquetiapine":[1,112],"may":[2,238],"be":[3,239],"a":[4,240],"pharmacologically":[5],"active":[6],"quetiapine":[7,18,22,42,71,88,127,134,157,176,215,244,248],"metabolite.":[8],"However,":[9],"information":[10],"on":[11],"plasma":[12,34,67,113,133,247],"concentrations":[13,35,114,217,230],"of":[14,28,36,121,196],"N-desalkylquetiapine":[15,229],"and":[16,41,47,56,61,79,92,126,148,150,156,170,175,214],"other":[17,57],"metabolites":[19,63],"attained":[20,44],"during":[21,45],"therapy":[23,46,101],"is":[24],"scant.":[25],"The":[26],"aim":[27],"this":[29],"study":[30],"was":[31,102,137,202],"to":[32,53,132,153],"investigate":[33],"quetiapine,":[37,211],"N-desalkylquetiapine,":[38],"O-desalkylquetiapine,":[39,212],"7-hydroxyquetiapine,":[40,213],"sulfoxide":[43,128,158,177,216],"analyze":[48],"the":[49,116],"data":[50],"with":[51,100,119,194],"respect":[52],"prescribed":[54,168],"dose":[55,83,120],"variables.":[58],"METHOD:":[59],"Quetiapine":[60,155],"its":[62],"were":[64,85,96,106,129,160,218,231],"measured":[65],"in":[66,141],"samples":[68,108,187],"submitted":[69],"for":[70,82,143,243],"therapeutic":[72],"drug":[73],"monitoring":[74],"(2009-2011).":[75],"Concentration,":[76],"metabolic":[77],"ratio,":[78],"concentration":[80],"corrected":[81],"(C/D)":[84],"investigated":[86],"against":[87],"dose,":[89],"age,":[90],"sex,":[91],"formulation.":[93],"Sample":[94],"results":[95],"excluded":[97],"if":[98],"nonadherence":[99],"queried.":[103],"RESULTS:":[104],"There":[105,136],"99":[107],"from":[109],"59":[110],"patients.":[111],"showed":[115,179],"strongest":[117],"correlation":[118,152],"all":[122],"analytes,":[123],"but":[124,200],"O-desalkylquetiapine":[125],"strongly":[130],"correlated":[131],"concentrations.":[135,249],"no":[138,151,203],"significant":[139,180,204],"difference":[140],"C/D":[142,159,178],"any":[144],"analyte":[145],"between":[146,166,185],"males":[147],"females":[149],"age.":[154],"significantly":[161,219],"different":[162],"(P":[163,182],"<":[164,183],"0.01)":[165],"patients":[167],"immediate-":[169],"extended-release":[171],"formulations.":[172],"Quetiapine,":[173],"7-hydroxyquetiapine":[174],"variation":[181],"0.02)":[184],"those":[186],"taken":[188],"10-14":[189],"hours":[190,198],"postdose":[191],"as":[192,206],"compared":[193],"that":[195],"16-24":[197],"postdose,":[199],"there":[201],"effect":[205],"regards":[207],"N-desalkylquetiapine.":[208],"CONCLUSIONS:":[209],"Plasma":[210,228],"affected":[220,233],"by":[221,234],"formulation":[222],"and/or":[223],"time":[224],"since":[225],"last":[226],"dose.":[227],"not":[232],"either":[235],"factor":[236],"therefore":[237],"better":[241],"marker":[242],"exposure":[245],"than":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2078747149","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
